Most women will never be screened for ovarian cancer. Unlike with breast and cervical cancers, ovarian cancer research has struggled to produce reliable methods of screening.
Over 20,000 women will be diagnosed with ovarian cancer this year in the United States, and less than half of them will still be alive in five years.
A report from the National Pharmaceutical Council (NPC) concludes that there is no “best” framework for determining the value of a health care product.
Women veterans are two times more likely than non-veteran women to die by suicide, and there is a dire need to improve their access to mental health services.
In comments to the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH), SWHR provided feedback on […]
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
The House Energy and Commerce Health Subcommittee holds a hearing on "Building Consumer Confidence by Empowering FDA to Improve Cosmetic Safety."